ono 1078 has been researched along with Acute Disease in 6 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
Acute Disease: Disease having a short and relatively severe course.
Excerpt | Relevance | Reference |
---|---|---|
"Conventional treatment for acute otitis media mainly targets bacteria with antibiotics, neglecting to control for mediators of inflammation." | 2.82 | The effect of the leukotriene antagonist pranlukast on pediatric acute otitis media. ( Esaki, S; Hamajima, Y; Miyamoto, N; Murakami, S; Nakamura, Y; Nakayama, M; Oshika, M; Sugiyama, K; Suzuki, M; Takagi, I; Yasui, K; Yokota, M, 2016) |
"Acute pancreatitis was induced in rats by intravenous infusion of a supramaximal dose of cerulein (5 micrograms/kg h for 4 h)." | 1.30 | Peptide leukotriene receptor antagonist diminishes pancreatic edema formation in rats with cerulein-induced acute pancreatitis. ( Hirano, T, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shi, QJ | 1 |
Wang, H | 1 |
Liu, ZX | 1 |
Fang, SH | 1 |
Song, XM | 1 |
Lu, YB | 1 |
Zhang, WP | 1 |
Sa, XY | 1 |
Ying, HZ | 1 |
Wei, EQ | 1 |
Nakamura, Y | 1 |
Hamajima, Y | 1 |
Suzuki, M | 1 |
Esaki, S | 1 |
Yokota, M | 1 |
Oshika, M | 1 |
Takagi, I | 1 |
Yasui, K | 1 |
Miyamoto, N | 1 |
Sugiyama, K | 1 |
Nakayama, M | 1 |
Murakami, S | 1 |
Matsuse, H | 1 |
Kondo, Y | 1 |
Machida, I | 1 |
Kawano, T | 1 |
Saeki, S | 1 |
Tomari, S | 1 |
Obase, Y | 1 |
Fukushima, C | 1 |
Mizuta, Y | 1 |
Kohno, S | 1 |
Hirano, T | 1 |
Schurman, SJ | 1 |
Alderman, JM | 1 |
Massanari, M | 1 |
Lacson, AG | 1 |
Perlman, SA | 1 |
Takahashi, N | 1 |
Iwanaga, T | 1 |
Aizawa, H | 1 |
Koto, H | 1 |
Watanabe, K | 1 |
Kishikawa, R | 1 |
Ikeda, T | 1 |
Shoji, S | 1 |
Nishima, S | 1 |
Hara, N | 1 |
1 trial available for ono 1078 and Acute Disease
Article | Year |
---|---|
The effect of the leukotriene antagonist pranlukast on pediatric acute otitis media.
Topics: Acute Disease; Anti-Bacterial Agents; Child; Child, Preschool; Chromones; Disease Progression; Drug | 2016 |
5 other studies available for ono 1078 and Acute Disease
Article | Year |
---|---|
HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
Topics: Acute Disease; Animals; Brain; Brain Edema; Brain Ischemia; Chromones; Cyclohexanecarboxylic Acids; | 2015 |
Effects of anti-inflammatory therapies on recurrent and low-grade respiratory syncytial virus infections in a murine model of asthma.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Antigens, Dermatophagoides; Asthma; Bronchoalveola | 2006 |
Peptide leukotriene receptor antagonist diminishes pancreatic edema formation in rats with cerulein-induced acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Body Water; Cathepsin B; Ceruletide; Chromones; Edema; Leukotriene | 1997 |
Tubulointerstitial nephritis induced by the leukotriene receptor antagonist pranlukast.
Topics: Acute Disease; Asthma; Biopsy; Child; Chromones; Creatinine; Follow-Up Studies; Glycosuria; Hematuri | 1998 |
Acute interstitial pneumonia induced by ONO-1078 (pranlukast), a leukotriene receptor antagonist.
Topics: Acute Disease; Anti-Asthmatic Agents; Asthma; Chromones; Diagnosis, Differential; Female; Humans; Le | 2001 |